HepatectomyLiver RegenerationLiver TransplantationTransplantation, HomologousKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationStem Cell TransplantationLiverTransplantation ConditioningGraft SurvivalOrgan TransplantationLiver NeoplasmsGraft RejectionLiving DonorsPancreas TransplantationTissue DonorsIslets of Langerhans TransplantationCell TransplantationTransplantationTransplantation ImmunologyTreatment OutcomeTime FactorsTransplantation ChimeraCarcinoma, HepatocellularLiver FailureImmunosuppressive AgentsRetrospective StudiesGraft vs Host DiseasePostoperative ComplicationsTransplantation, IsogeneicPortal VeinTransplantation, HeterotopicLiver DiseasesCord Blood Stem Cell TransplantationHeart-Lung TransplantationTissue and Organ ProcurementTransplantation ToleranceHepatocytesPeripheral Blood Stem Cell TransplantationSurvival RateImmunosuppressionHistocompatibility TestingFetal Tissue Transplantation2-AcetylaminofluoreneFollow-Up StudiesHepatic VeinsRecurrenceSkin TransplantationTissue and Organ HarvestingLiver Function TestsSurvival AnalysisRats, Inbred F344Waiting ListsTransplantation, HeterologousBile Ducts, IntrahepaticMesenchymal Stem Cell TransplantationHepatic ArteryCorneal TransplantationHistocompatibilityHematologic NeoplasmsTacrolimusBile Duct NeoplasmsTissue TransplantationLithiasisDiethylnitrosamineWhole-Body IrradiationCyclosporinePostoperative PeriodPreoperative CareCadaverRisk FactorsLiver CirrhosisLiver CirculationBlood Loss, SurgicalLiver Failure, AcuteBile DuctsBrain Tissue TransplantationPrognosisMice, Inbred C57BLCholangiocarcinomaCombined Modality TherapyBilirubinFacial TransplantationDonor SelectionDisease-Free SurvivalOrgan SizePatient SelectionOrgan PreservationLiver Neoplasms, ExperimentalBusulfanModels, AnimalTransplantsHepatic Duct, CommonProspective StudiesRats, Inbred LewHLA Antigens